-
mechanisms behind heart defects and cardiomyopathies using cutting-edge technologies such as human induced-pluripotent stem cells (hiPSCs), CRISPR gene editing, 3D organoids, and engineered heart tissues. Our
-
the opportunity to contribute to impactful antimalarial drug discovery projects, focusing on the mechanisms of action and resistance of both existing and novel antimalarials. The ultimate goal is to develop
-
mechanisms behind heart defects and cardiomyopathies using cutting-edge technologies such as human induced-pluripotent stem cells (hiPSCs), CRISPR gene editing, 3D organoids, and engineered heart tissues. Our
-
design coordination, addressing inefficiencies that arise when diverse expertise (e.g. structural and mechanical engineering) intersects during the design process. This role involves developing